PTEN Expression, Not Mutation Status in <i>TSC1, TSC2</i>, or <i>mTOR</i>, Correlates with the Outcome on Everolimus in Patients with Renal Cell Carcinoma Treated on the Randomized RECORD-3 Trial

Martin H. Voss, Robert J. Motzer, Mahtab Marker et al.|Clinical Cancer Research|2018

Cited by 38